Table 4 Standardized path coefficients for the structural model

Capacity to obtain

HPV-related information

HPV knowledge

-0.148

0.485

-1.953

0.051

HPV knowledge

Those who have intention to take up HPV vaccine no matter what the price is vs. the reference^a

0.173

0.006

2.329

0.020

Perceived severity

Those who have intention to take up HPV vaccine no matter what the price is vs. the reference^a

0.016

0.054

0.174

0.862

Subjective norm

Those who have intention to take up HPV vaccine no matter what the price is vs. the reference^a

0.079

0.067

0.791

0.429

Perceived benefits

Those who have intention to take up HPV vaccine no matter what the price is vs. the reference^a

0.020

0.066

0.220

0.826

Perceived barriers

Those who have intention to take up HPV vaccine no matter what the price is vs. the reference^a

-0.119

0.070

-1.536

0.125

HPV knowledge

Those who have intention to take up HPV vaccine if the price is below NT$8000 vs. the reference^a

0.059

0.005

0.770

0.441

Perceived severity

Those who have intention to take up HPV vaccine if the price is below NT$8000 vs. the reference^a

0.059

0.040

0.389

0.697

Subjective norm

Those who have intention to take up HPV vaccine if the price is below NT$8000 vs. the reference^a

0.112

0.049

0.751

0.453

Perceived benefits

Those who have intention to take up HPV vaccine if the price is below NT$8000 vs. the reference^a

0.043

0.060

1.090

0.276

Perceived barriers

Those who have intention to take up HPV vaccine if the price is below NT$8000 vs. the reference^a

0.066

0.052

0.832

0.405

Those who have intention to take up HPV vaccine no matter what the price is vs. the reference^a

Vaccine uptake in the 6^th month follow-up

0.261

0.059

3.323

 < 0.001

Those who have intention to take up HPV vaccine if the price is below NT$8000 vs. the reference^a

Vaccine uptake in the 6^th month follow-up

-0.006

0.081

-0.080

0.936

HPV screening

Vaccine uptake in the 6^th month follow-up

0.208

0.056

2.884

0.004